WEDNESDAY, Nov. 8, 2023 (HealthDay News) — A second injectable diabetes drug has been approved for weight loss in overweight and obese adults, the U.S. Food and Drug Administration announced Wednesday. The weight-loss drug Zepbound contains the same active ingredient, tirzepatide, as the diabetes drug Mounjaro. Both medications are madeContinue Reading

WEDNESDAY, Nov. 8, 2023 (HealthDay News) — “Davey” Bauer hovered on the precipice of death, his lungs damaged by vaping and congested by antibiotic-resistant pneumonia. Doctors saved his life with a jury-rigged artificial lung, a prompt double-lung transplant… and a set of DD breast implants. Doctors at Northwestern Medicine craftedContinue Reading